Table 4 |
|||||||||||||||||
|
Prospective associations between mobile phone variables at baseline and mental health outcomes at 1-year follow-up |
|||||||||||||||||
|
CURRENT STRESS |
SLEEP DISTURBANCES |
SYMPTOMS OF DEPRESSION One item |
SYMPTOMS OF DEPRESSION Two items |
||||||||||||||
|
n |
Prev % |
PR |
95% CI |
n |
Prev % |
PR |
95% CI |
n |
Prev % |
PR |
95% CI |
n |
Prev % |
PR |
95% CI |
||
|
|
|||||||||||||||||
|
Mobile phone use |
|||||||||||||||||
|
Men |
High |
227 |
8 |
0.9 |
0.51-1.47 |
193 |
21 |
1.8 |
1.21-2.69 |
120 |
38 |
1.7 |
1.14-2.46 |
86 |
13 |
1.1 |
0.53-2.10 |
|
Medium |
258 |
11 |
1.2 |
0.76-1.87 |
243 |
17 |
1.4 |
0.98-2.11 |
121 |
30 |
1.4 |
0.94-2.10 |
105 |
19 |
1.5 |
0.86-2.53 |
|
|
Low |
652 |
10 |
1.0 |
596 |
13 |
1.0 |
333 |
23 |
1.0 |
305 |
15 |
1.0 |
|||||
|
Women |
High |
389 |
20 |
1.1 |
0.84-1.43 |
323 |
24 |
1.2 |
0.91-1.57 |
131 |
39 |
1.2 |
0.88-1.69 |
120 |
33 |
1.5 |
1.02-2.24 |
|
Medium |
382 |
18 |
1.0 |
0.75-1.30 |
367 |
20 |
1.1 |
0.81-1.40 |
161 |
31 |
0.9 |
0.68-1.30 |
150 |
26 |
1.2 |
0.83-1.79 |
|
|
Low |
968 |
19 |
1.0 |
909 |
19 |
1.0 |
435 |
33 |
1.0 |
370 |
22 |
1.0 |
|||||
|
Availability demands |
|||||||||||||||||
|
Men |
High |
296 |
14 |
1.6 |
0.97-2.56 |
261 |
19 |
1.4 |
0.91-2.12 |
137 |
30 |
1.2 |
0.76-1.85 |
120 |
20 |
1.6 |
0.88-3.05 |
|
Medium |
525 |
8 |
0.9 |
0.56-1.44 |
491 |
14 |
1.0 |
0.66-1.45 |
285 |
26 |
1.0 |
0.70-1.52 |
246 |
15 |
1.1 |
0.63-1.96 |
|
|
Low |
314 |
9 |
1.0 |
280 |
15 |
1.0 |
152 |
26 |
1.0 |
131 |
14 |
1.0 |
|||||
|
Women |
High |
390 |
22 |
1.3 |
0.99-1.76 |
342 |
22 |
1.1 |
0.81-1.45 |
146 |
32 |
0.9 |
0.62-1.23 |
141 |
30 |
1.4 |
0.94-2.17 |
|
Medium |
722 |
19 |
1.1 |
0.87-1.45 |
655 |
20 |
1.0 |
0.79-1.30 |
281 |
31 |
0.8 |
0.63-1.12 |
263 |
26 |
1.2 |
0.85-1.78 |
|
|
Low |
625 |
17 |
1.0 |
599 |
19 |
1.0 |
299 |
37 |
1.0 |
235 |
20 |
1.0 |
|||||
|
Awakened at night |
|||||||||||||||||
|
Men |
High |
138 |
13 |
1.4 |
0.80-2.42 |
116 |
21 |
1.4 |
0.90-2.31 |
57 |
32 |
1.1 |
0.68-1.94 |
48 |
19 |
1.4 |
0.65-2.86 |
|
Medium |
516 |
10 |
1.1 |
0.71-1.60 |
462 |
15 |
1.0 |
0.74-1.47 |
264 |
27 |
1.0 |
0.74-1.45 |
225 |
15 |
1.0 |
0.63-1.65 |
|
|
Low |
485 |
9 |
1.0 |
456 |
15 |
1.0 |
254 |
26 |
1.0 |
224 |
16 |
1.0 |
|||||
|
Women |
High |
268 |
22 |
1.2 |
0.86-1.60 |
229 |
23 |
1.2 |
0.87-1.68 |
96 |
39 |
1.2 |
0.84-1.81 |
78 |
24 |
1.1 |
0.62-1.80 |
|
Medium |
791 |
17 |
0.9 |
0.70-1.12 |
740 |
20 |
1.1 |
0.86-1.39 |
324 |
33 |
1.0 |
0.78-1.34 |
299 |
28 |
1.3 |
0.90-1.77 |
|
|
Low |
680 |
20 |
1.0 |
630 |
19 |
1.0 |
307 |
33 |
1.0 |
263 |
22 |
1.0 |
|||||
|
Accessibility stress |
|||||||||||||||||
|
Men |
High |
80 |
19 |
2.2 |
1.22-3.80 |
94 |
23 |
1.7 |
1.06-2.71 |
25 |
24 |
0.9 |
0.40-2.14 |
27 |
30 |
2.3 |
1.06.4.98 |
|
Medium |
317 |
11 |
1.3 |
0.88-2.01 |
288 |
16 |
1.2 |
0.84-1.69 |
145 |
32 |
1.3 |
0.89-1.79 |
123 |
20 |
1.6 |
0.96-2.56 |
|
|
Low |
740 |
9 |
1.0 |
651 |
14 |
1.0 |
404 |
25 |
1.0 |
347 |
13 |
1.0 |
|||||
|
Women |
High |
176 |
32 |
2.2 |
1.61-3.00 |
181 |
27 |
1.5 |
1.10-2.14 |
54 |
43 |
1.3 |
0.82-2.03 |
58 |
47 |
2.4 |
1.50-3.68 |
|
Medium |
677 |
21 |
1.5 |
1.15-1.85 |
645 |
21 |
1.2 |
0.96-1.54 |
280 |
35 |
1.1 |
0.84-1.42 |
241 |
24 |
1.2 |
0.82-1.63 |
|
|
Low |
885 |
15 |
1.0 |
773 |
18 |
1.0 |
393 |
32 |
1.0 |
341 |
21 |
1.0 |
|||||
|
Over-use |
|||||||||||||||||
|
Men |
High |
26 |
12 |
1.2 |
0.36-3.71 |
23 |
22 |
1.4 |
0.58.3.49 |
11 |
54 |
1.9 |
0.82-4.45 |
7 |
29 |
2.0 |
0.48-8.43 |
|
Medium |
141 |
13 |
1.3 |
0.79-2.18 |
129 |
13 |
0.9 |
0.52-1.43 |
67 |
28 |
1.1 |
0.68-1.80 |
53 |
9 |
0.6 |
0.25-1.55 |
|
|
Low |
953 |
10 |
1.0 |
866 |
16 |
1.0 |
484 |
26 |
1.0 |
428 |
16 |
1.0 |
|||||
|
Women |
High |
98 |
21 |
1.3 |
0.80-1.97 |
94 |
32 |
1.8 |
1.21-2.62 |
35 |
29 |
0.9 |
0.46-1.63 |
33 |
24 |
1.1 |
0.51-2.16 |
|
Medium |
353 |
24 |
1.4 |
1.08-1.79 |
323 |
24 |
1.4 |
1.06-1.78 |
125 |
40 |
1.2 |
0.89-1.66 |
109 |
31 |
1.4 |
0.92-2.00 |
|
|
Low |
1269 |
17 |
1.0 |
1163 |
18 |
1.0 |
560 |
33 |
1.0 |
491 |
23 |
1.0 |
|||||
|
|
|||||||||||||||||
|
Participants who reported symptoms at baseline were excluded from prospective analysis of mental health outcome concerned. Study group n in prospective analysis was for Current stress: 1222 men and 1913 women, Sleep disturbances: 1107 men and 1762 women, Symptoms of depression (one item): 617 men and 791 women, and Symptoms of depression (two items): 534 men and 692 women. Prevalence (prev %) of mental health symptoms at 1-year follow-up in each exposure category is shown. The prevalence ratios (PRs) with 95% confidence intervals (CIs) were adjusted for relationship status, educational level and occupation. Missing values (non-responses to items) were excluded from the analyses, which means that the n varied in the analyses. Prevalence ratios with a CI not including 1.00 are given in bold. |
|||||||||||||||||
|
Thomée et al. BMC Public Health 2011 11:66 doi:10.1186/1471-2458-11-66 |
|||||||||||||||||